))
Ep. 19 Neuroblastoma: emerging treatment strategies
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on January 27, 2024 09:12 (
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 396903642 series 3540536
Content provided by Prashant Jambunathan. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Prashant Jambunathan or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
We will discuss the emerging treatment landscape of Neuroblastoma, beyond Dinutuximab. We begin with Naxitamab, followed by the role of ALK inhibitors like Ceritinib and Crizotinib. We then move on to AURORA inhibitors, and other newer treatment modalities in phase 1 and 2 clinical trials.
22 episodes
Share
